US company: vaccine trial against Coronavirus shows, according to the study, first, good results

In the race for a Corona vaccine, the US have taken a step forward. An experimental means of the US Biotech company Moderna shows according to a study, the first encouraging results. So would have developed in the first Phase of clinical Tests, the subjects antibodies to the causative agent of Sars-CoV-2, explained that the study involved a National Institute for allergies and infectious diseases (NIAID). In the case of the 45 participants in the age from 18 to 55 years, there have been no serious side effects, it was more. Now the Tests should soon go to a much larger scale.

Aerosols on the plane

Researchers warn: In the plane, the risk is great, the Coronavirus to infect

Around the globe researchers and companies to search feverishly after a Corona vaccine. Currently be tested, according to the world health organization, more than 20 agents in clinical trials in humans. Some of it has already been shown that subjects develop after the vaccination, antibodies against Sars-CoV-2. It is unclear, however, whether a Vaccinated is actually immune to infection with the Coronavirus. This is examined in the so-called Phase III studies with Thousands of subjects.

Yet to most in the research process, the UK and China. The University of Oxford started to cooperate with the pharmaceutical company AstraZeneca a Phase III study, the Chinese company Sinovac is on the verge of. A vaccine is considered essential building block for the suppression of Corona-pandemic.

Corona vaccine: manufacturer speaks of “robust immune response”

The subjects of the US Biotech firm Moderna, which is received within a period of two months, two injections of the vaccine, developed more neutralizing antibodies than persons for whom a Coronavirus was the infection been diagnosed, as it was called on Tuesday (local time) more. The researchers presented the results of a study in the “New England Journal of Medicine”. The manufacturer Moderna said in a message from a “robust immune response”, which is now the way for much larger studies on the efficacy level.

The vaccine mRNA-1273 is to be tested at the end of July in a Phase III study of approximately 30,000 volunteers. The study is expected to last until October 2022, results there can be but previously.

In the Tests of the first Phase of the vaccines are tested only on a few volunteers, because it is first and foremost to the examination of the compatibility. After the first positive results Moderna had extended the first Phase to 120 volunteers to test the safety of the vaccine in the elderly. The results of the expanded study is not available yet.

Due to the short study period was also not yet clear whether and how long the antibodies could protect the subjects, in fact, an infection with the Coronavirus. The blood of the participants should therefore be assessed on a regular basis on the proportion of antibodies, said the study.

In the case of Modernas preparation, it is a so-called RNA vaccine. So far, worldwide, there are still no approved Human vaccines, the use of this procedure.

Also, the Mainz-based Biopharma company Biontech and the US company Pfizer are working together on such a vaccine. They stated in the beginning of July, that subjects, BNT in the case of Tests in the United States after an injection of the experimental vaccine 162b1 effective antibodies have developed. Here, too, now larger Tests are expected to follow.

New in health

Current Virus Situation

Further loosening in many States, an expert warns "Super-Spreadern"

Current Virus Situation

Further loosening in many States, an expert warns "Super-Spreadern"


You had the feeling that Corona is "vorbei": 1000 people celebrating at unangekündigtem Rave

Artist "Odeith"

Graffiti artist creates incredibly lifelike illusions

Skin clear

Blackheads remove – so your skin pores clean

Persistent Complaints

Recover, but not healthy: The long Suffering of some of the Covid-19-patients

Hair care

Healthy hair to the tips: how to apply argan oil right

69 days in the hospital

Covid-19-Patient is surprisingly healthy again – his wife had already adopted

Appearances on Corona-Demos

Austrian Impfgegnerin can continue to work as a Doctor in a clinic

Imperial College London

Due to Corona: experts, more death to be feared cases of Malaria, HIV and tuberculosis

Super spreader in China

Woman’s neighbors in the Elevator with Corona – a total of 71 people infected

David Bennent

What is the Boy from &#034 power;The Blechtrommel" today?

Natural Hair Wash

Is hair soap a meaningful or meaningless Alternative to Shampoo?

Rising Infection Numbers

Bars, cinemas and churches closing: California is back in the Lockdown

Before infection of time from the fall of

Children’s doctors criticize: day care centers send children out of fear of Corona to home quickly

Report from Texas

30-Year-old held Coronavirus for a "Scherz" and dies after "Covid-19-Party"

Corona in holiday times

Spahn warns of second wave of Infection: "Need to watch out for that ball, man is not the second Ischgl wird"

Night’s sleep

How do Anti-snore pillow and for whom are they suitable?

Pounds lose

Ten pounds in two weeks lose weight? Reporter test the Thonon diet

Relieve pain

So you can detect a bed of nails-ignition – and so they will treat you right

Fitness Trend

EMS Training – how it works and who it really is


Doctors test the blood of the first German Corona-patients – knowledge dampens hope for vaccine

The U.S. state of

California is the model student was, now the Corona is slipping from crisis completely